Digital Therapeutics Market

Digital Therapeutics Market was valued at USD 3,539.1 million in 2022 and is forecast to touch USD 18,662.1 million in 2030, and the market is expected to grow at a CAGR of 23.1% from 2023-2030.

To have an edge over the competition by knowing the market dynamics and current trends of “Digital Therapeutics Market”, request for Sample Report here

Key Digital therapeutics Market Drivers

Increasing prevalence of chronic disease stands to be one of the key market drivers of the Digital Therapeutics market. Caring for individuals who suffer from chronic health condition, such as diabetes, high blood pressure, congestive heart failure and chronic obstructive pulmonary disease, costs the US healthcare system billions of dollars annually. According to Centers for Disease Control and prevention, in United States 6 out of 10 adults have at least one chronic health condition, and 4 out of 10 adults have two or more. They are also the leading driver of USD 3.8 trillion annual health care costs in the US. With the adoption of evidence-based digital therapeutics, healthcare organizations can alleviate the mounting cost of caring for an increasing number of patients with chronic health conditions. For instance, Verily (subsidiary of Alphabet Inc.), developed study watch with irregular pulse monitor in collaboration with iRhythm for continuous monitoring, data analytics and cloud-based machine learning to create innovative solutions for screening and monitoring atrial fibrillation (AFib).

Restraint in the Digital Therapeutics Market

There is still uncertainty regarding the appropriate legal grounds for the processing of data in the context of digital health matters. Transforming the system by incorporating digital health is a complex, costly, and lengthy task in which the interests of all parties need to be reconciled. Considerations of cybersecurity and data rights are preconditions for the mass adoption of digital therapeutics. As digital therapeutics solutions and services are transferred information over the internet, risks of unauthorized access and manipulation of these products and underlying data could compromise both trust in the product and patient care.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Type – Segment Analysis

Based on Type, the Software segment stands as the largest segment for Digital Therapeutics Market in 2021. The factors propelling the growth of the market in this segment is due to the growing number of launches of software and apps by the digital therapeutics’ companies for the health management. For instance, Happify Health, announced the launch of Ensemble, the first and only transdiagnostic prescription digital therapeutic for the treatment of patients who have Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD).

Application- Segment Analysis

Based on application, the Diabetes segment accounted for the largest share in the digital therapeutics market owing to the increasing number of cases and prevalence of diabetes globally, thereby positively contributing to the growth of this segment in the digital therapeutics market. Moreover, rising launches of digital therapeutics digital therapeutics program for diabetes and lifestyle management such as “LIFEMAP,” is driving the growth of this segment.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Top Market Players

Various notable players operating in the Digital Therapeutics market include Omada Health, Inc., DarioHealth Corp., Livongo, Welldoc’s BlueStar, Voluntis, Happify Health, Propeller Health, Kaia Health Software Inc., Pear Therapeutics, Inc., Akili Interactive Labs, Inc among others. 

Key Developments:

• • In 2021, DarioHealth Corp. launched Dario Move, a new digital physical therapy solution to manage common musculoskeletal (MSK) conditions that drive significant costs for employers and health plans.
  • In 2021, Welldoc’s and Dexcom expanded strategic partnership for a new integrated platform offering to improve health of people with Type 2 diabetes. The Dexcom G6 system measures glucose level beneath the surface of skin, and BlueStar guides individual through complicated journey of living with diabetes.
  • In 2021, Voluntis announced the issuance of a new patent by the European Patent Office(EPO) for intelligent patient support in drug dosing applied in the field of diabetes for insulin titration with Its Theraxium digital therapeutic platform.

Segments covered in the Report:

The Digital Therapeutics Market has been segmented on the basis of Type, Sales Channel, and Application. Based on the Type, the market has been segmented into Hardware, Software and Services.

Based on the Sales Channel, the market has been segmented into B2B and B2C. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Neurological Disorders, Respiratory Diseases, Prediabetes, Obesity, Smoking Cessation and Others 

For detailed scope of the “Digital Therapeutics Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is Digital Therapeutics Market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in Digital Therapeutics Market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the Digital Therapeutics market?
  • Which type generated maximum revenues in 2022 and identify the most promising type during the forecast period?
  • What application segment in leading in Digital Therapeutics Market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Market Segmentation

Digital Therapeutics Market by Type

• • Hardware
  • Software
  • Services

Digital Therapeutics Market by Sales Channel

• • B2B
  • B2C

Digital Therapeutics Market by Application

• • Cardiovascular Diseases
  • Diabetes
  • Neurological Disorders
  • Respiratory Diseases
  • Prediabetes
  • Obesity
  • Smoking Cessation
  • Others

Digital Therapeutics Market by Region

• • North America Digital Therapeutics Market (Option 1: As a part of the free 25% customization)
    • By Type
    • By Sales Channel
    • By Application
    • US Market All-Up
    • Canada Market All-Up
  • Europe Digital Therapeutics Market (Option 2: As a part of the free 25% customization)
    • By Type
    • By Sales Channel
    • By Application
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific Digital Therapeutics Market (Option 3: As a part of the free 25% customization)
    • By Type
    • By Sales Channel
    • By Application
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW Digital Therapeutics Market (Option 4: As a part of the free 25% customization)
    • By Type
    • By Sales Channel
    • By Application
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Major Players Operating in the Digital Therapeutics (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Omada Health, Inc.
  • DarioHealth Corp.
  • Livongo
  • Welldoc’s BlueStar
  • Voluntis
  • Happify Health
  • Propeller Health
  • Kaia Health Software Inc.
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc